UONDDL
BIIB icon

University of Notre Dame du Lac’s Biogen BIIB Stock Holding History

University of Notre Dame du Lac’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-30,470
Closed -$8.64M – 72
2016
Q4 		$8.64M Buy
30,470
+23,559
+341% +$6.98M 3.46% 7
2016
Q3 		$2.16M Buy
+6,911
New +$2.05M 1.87% 27

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

University of Notre Dame du Lac's BIIB Position: Q1 2017 in Review

University of Notre Dame du Lac sold out of Biogen (BIIB) in Q1 2017, closing a stake of 30,470 shares — an estimated $8.64M sold.

University of Notre Dame du Lac first reported a position in BIIB in Q3 2016 and held it in 2 quarters. The position peaked at $8.64M in Q4 2016. 1,020 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

  • University of Notre Dame du Lac reported no remaining Biogen position as of Q1 2017 after selling out during the quarter.
  • University of Notre Dame du Lac sold 30,470 Biogen shares in Q1 2017, an estimated $8.64M.
  • University of Notre Dame du Lac first reported a position in Biogen in Q3 2016 and held it in 2 quarters.
  • University of Notre Dame du Lac's Biogen position peaked at $8.64M in Q4 2016.
  • 1,020 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on University of Notre Dame du Lac's 13F filing for Q1 2017, filed 12 May 2017.